population health

Research in Review

Nurse Navigators Crucial to Improving Care for Patients With Blood Cancers

06/20/2017

JCP Editors

Nurse navigation focused on the patient and family across the care continuum can effectively guide patients with blood cancer to better care and quality of life (QoL), according to a presentation at the 2017 Oncology...

Nurse...

06/20/2017

Journal of Clinical Pathways

Research in Review

Hypomethylating Agents Improve Survival in Older Patients With CMML

06/19/2017

JCP Editors

Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...

Older...

06/19/2017

Journal of Clinical Pathways

Research in Review

Adding Targeted Therapy Improves CAR-T Response Rates in CLL

06/15/2017

JCP Editors

Researchers report significantly improved response rates in patients with chronic lymphocytic leukemia (CLL) treated with concurrent targeted therapy and chimeric antigen receptor T-cell (CAR-T)...

...

06/15/2017

Journal of Clinical Pathways

Research in Review

TKI Safe and Effective in Pediatric CML

06/15/2017

JCP Editors

A recent study demonstrated high response rates and tolerable safety profiles in pediatric patients with chronic myeloid leukemia (CML) after treatment with a tyrosine kinase inhibitor (TKI). ----- Related...

A...

06/15/2017

Journal of Clinical Pathways

Research in Review

Underuse of Hospice Care for Blood Cancers Linked to Inadequate Services

06/14/2017

JCP Editors

Hematologic oncologists are hesitant to refer patients to hospice care due to their views of inadequate services offered there, according to study results published in Cancer (published online May 22, 2017;...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End of Life

06/14/2017

JCP Editors

Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Testing Guidelines Omit Critical Genetic Features

06/13/2017

JCP Editors

Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Biologic Therapy Not Cost-Effective in Patients With RA

06/13/2017

JCP Editors

A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...

A...

06/13/2017

Journal of Clinical Pathways

Research in Review

High Response Rates With New Treatment for Aggressive B-Cell Lymphoma

06/13/2017

JCP Editors

In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...

In a...

06/13/2017

Journal of Clinical Pathways

Research in Review

Type of Low-Grade Tumor Commonly Over-Diagnosed, Study Suggests

06/12/2017

JCP Editors

A recent study showed that over 65% of cases of a certain tumor type were over-diagnosed or inaccurately risk-stratified, published in PLOS One (June 7, 2017;12[6]:e0179216). ----- Related Content Modified...

A...

06/12/2017

Journal of Clinical Pathways